


To provide capital growth and income.
| Name | % Net Assets |
|---|---|
| GlaxoSmithKline PLC | 5.2% |
| Vodafone Group PLC | 5.2% |
| Royal Dutch Shell | 5.0% |
| Vodafone | 4.8% |
| AstraZeneca | 4.6% |
| BP | 4.3% |
| British American Tobacco PLC | 3.9% |
| Imperial Tobacco Group PLC | 3.6% |
| British Gas | 3.2% |
| Centrica | 2.3% |
| Key | % Net Assets |
|---|---|
| 5.2% | |
| 5.2% | |
| 5.0% | |
| 4.8% | |
| 79.8% |
| Date | n/a |
|---|---|
| Bid | 0.00 |
| Offer | 0.00 |
| Currency | n/a |
| Change | 0.00 |
| % | n/a |
| YTD change | 0.00 |
| YTD % | n/a |
| Fund Inception | 13/02/2004 |
|---|---|
| Fund Manager | n/a |
| TER | 1.97 (30-Jun-2009) |
| Minimum Investment | |
|---|---|
| Initial | 1000 |
| Additional | n/a |
| Savings | 50 |
| Charges | |
|---|---|
| Initial | 5.00% |
| Annual Mang't | 1.50% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.01 |
| Sharpe ratio | 0.06 |
You are here: research